<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1020-3397</journal-id>
<journal-title><![CDATA[Eastern Mediterranean Health Journal]]></journal-title>
<abbrev-journal-title><![CDATA[East. Mediterr. health j.]]></abbrev-journal-title>
<issn>1020-3397</issn>
<publisher>
<publisher-name><![CDATA[Alexandria: WHO, Regional Office for the Eastern Mediterranean]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1020-33972007000500011</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Seroprevalence of toxocariasis in children aged 1-9 years in western Islamic Republic of Iran, 2003]]></article-title>
<article-title xml:lang="fr"><![CDATA[Séroprévalence de la toxocariose chez l'enfant de 1 à 9 ans dans la région occidentale de la République islamique d'Iran en 2003]]></article-title>
<article-title xml:lang="ar"><![CDATA[&#1605;&#1593;&#1583;&#1604; &#1575;&#1604;&#1575;&#1606;&#1578;&#1588;&#1575;&#1585; &#1575;&#1604;&#1605;&#1589;&#1604;&#1610; &#1604;&#1583;&#1575;&#1569; &#1575;&#1604;&#1587;&#1607;&#1605;&#1610;&#1575;&#1578; &#1576;&#1610;&#1606; &#1575;&#1604;&#1571;&#1591;&#1601;&#1575;&#1604; &#1605;&#1606; &#1593;&#1605;&#1585; 1 &#1573;&#1604;&#1609; 9 &#1587;&#1606;&#1608;&#1575;&#1578; &#1601;&#1610; &#1594;&#1585;&#1576; &#1580;&#1605;&#1607;&#1608;&#1585;&#1610;&#1577; &#1573;&#1610;&#1585;&#1575;&#1606; &#1575;&#1604;&#1573;&#1587;&#1604;&#1575;&#1605;&#1610;&#1577; &#1587;&#1606;&#1577; 2003]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fallah]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Azimi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Taherkhani]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Hamadan University of Medical Sciences School of Medicine Department of Parasitology and Mycology]]></institution>
<addr-line><![CDATA[Hamadan ]]></addr-line>
<country>Islamic Republic of Iran</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Atieh Hospital  ]]></institution>
<addr-line><![CDATA[Hamadan ]]></addr-line>
<country>Islamic Republic of Iran</country>
</aff>
<aff id="A03">
<institution><![CDATA[,Gorgan University of Medical Sciences  ]]></institution>
<addr-line><![CDATA[Gorgan ]]></addr-line>
<country>Islamic Republic of Iran</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2007</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2007</year>
</pub-date>
<volume>13</volume>
<numero>5</numero>
<fpage>1073</fpage>
<lpage>1077</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://eastern.mediterranean.scielo.org/scielo.php?script=sci_arttext&amp;pid=S1020-33972007000500011&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://eastern.mediterranean.scielo.org/scielo.php?script=sci_abstract&amp;pid=S1020-33972007000500011&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><self-uri xlink:href="http://eastern.mediterranean.scielo.org/scielo.php?script=sci_pdf&amp;pid=S1020-33972007000500011&amp;lng=en&amp;nrm=iso&amp;tlng=en"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[We determined the seroprevalence of Toxocara canis infection in 544 children under 10 years randomly selected from urban and rural areas of Hamadan. An enzyme-linked immunosorbent assay was used for detection of antibodies to T. canis excretion-secretion antigens. Using a questionnaire, epidemiological factors associated with infection were examined, including age, sex, residence. Antibodies to T. canis were detected in 29 children (5.3%) and 19 children (3.5%) were categorized as borderline positive; thus together this gave a prevalence of toxocariasis of 8.8%. No significant differences were found in terms of sex, age and residence.]]></p></abstract>
<abstract abstract-type="short" xml:lang="fr"><p><![CDATA[Nous avons déterminé la séroprévalence de l’infection à Toxocara canis chez 544 enfants de moins de 10 ans résidant dans les zones rurales et urbaines d’Hamadan et sélectionnés au hasard. La détection des anticorps contre les antigènes excrétoires-sécrétoires de T. canis a été effectuée à l’aide d’un test immunoenzymatique (ELISA, pour enzyme-linked immunosorbent assay). Un questionnaire a permis l’évaluation des facteurs épidémiologiques associés à l’infection, notamment l’âge, le sexe et le lieu de résidence. Des anticorps anti-T. canis ont été détectés chez 29 enfants (5,3 %), tandis qu’une positivité limite a été enregistrée chez 19 autres (3,5 %), établissant ainsi une prévalence de la toxocariose à 8,8 %. Aucune différence significative n’est apparue liée à l’âge, au sexe ou au lieu de résidence.]]></p></abstract>
<abstract abstract-type="short" xml:lang="ar"><p><![CDATA[&#1575;&#1604;&#1582;&#1604;&#1575;&#1589;&#1600;&#1577; &#1583;&#1585;&#1587; &#1575;&#1604;&#1576;&#1575;&#1581;&#1579;&#1608;&#1606; &#1605;&#1593;&#1583;&#1604; &#1575;&#1604;&#1575;&#1606;&#1578;&#1588;&#1575;&#1585; &#1575;&#1604;&#1605;&#1589;&#1604;&#1610; &#1604;&#1604;&#1593;&#1583;&#1608;&#1609; &#1576;&#1575;&#1604;&#1587;&#1607;&#1605;&#1610;&#1575;&#1578; &#1575;&#1604;&#1603;&#1604;&#1576;&#1610;&#1577; &#1604;&#1583;&#1609; 544 &#1591;&#1601;&#1604;&#1575;&#1611; &#1583;&#1608;&#1606; &#1587;&#1606; &#1575;&#1604;&#1593;&#1575;&#1588;&#1585;&#1577;&#1548; &#1575;&#1582;&#1578;&#1610;&#1585;&#1608;&#1575; &#1593;&#1588;&#1608;&#1575;&#1574;&#1610;&#1575;&#1611; &#1605;&#1606; &#1575;&#1604;&#1605;&#1606;&#1575;&#1591;&#1602; &#1575;&#1604;&#1585;&#1610;&#1601;&#1610;&#1577; &#1608;&#1575;&#1604;&#1581;&#1590;&#1585;&#1610;&#1577; &#1601;&#1610; &#1607;&#1605;&#1583;&#1575;&#1606;. &#1608;&#1575;&#1587;&#1578;&#1582;&#1583;&#1605;&#1608;&#1575; &#1605;&#1602;&#1575;&#1610;&#1587;&#1577; &#1575;&#1604;&#1605;&#1605;&#1578;&#1586; &#1575;&#1604;&#1605;&#1606;&#1575;&#1593;&#1610; &#1575;&#1604;&#1605;&#1585;&#1578;&#1576;&#1591; &#1576;&#1575;&#1604;&#1573;&#1606;&#1586;&#1610;&#1605; &#1604;&#1603;&#1588;&#1601; &#1571;&#1590;&#1583;&#1575;&#1583; &#1575;&#1604;&#1587;&#1607;&#1605;&#1610;&#1575;&#1578; &#1575;&#1604;&#1603;&#1604;&#1576;&#1610;&#1577; &#1608;&#1605;&#1587;&#1578;&#1590;&#1583;&#1575;&#1578; &#1605;&#1601;&#1585;&#1594;&#1575;&#1578;&#1607;&#1575; &#1608;&#1605;&#1601;&#1585;&#1586;&#1575;&#1578;&#1607;&#1575;&#1563; &#1608;&#1583;&#1585;&#1587;&#1608;&#1575;&#1548; &#1576;&#1575;&#1587;&#1578;&#1582;&#1583;&#1575;&#1605; &#1575;&#1587;&#1578;&#1576;&#1610;&#1575;&#1606; &#1582;&#1575;&#1589;&#1548; &#1575;&#1604;&#1593;&#1608;&#1575;&#1605;&#1604;&#1614; &#1575;&#1604;&#1573;&#1576;&#1610;&#1583;&#1610;&#1605;&#1610;&#1608;&#1604;&#1608;&#1580;&#1610;&#1577; &#1575;&#1604;&#1605;&#1585;&#1575;&#1601;&#1602;&#1577; &#1604;&#1604;&#1593;&#1583;&#1608;&#1609;&#1548; &#1608;&#1578;&#1588;&#1605;&#1604; &#1575;&#1604;&#1593;&#1605;&#1585;&#1548; &#1608;&#1575;&#1604;&#1580;&#1606;&#1587;&#1548; &#1608;&#1605;&#1581;&#1604; &#1575;&#1604;&#1573;&#1602;&#1575;&#1605;&#1577;. &#1608;&#1575;&#1603;&#1578;&#1588;&#1601; &#1575;&#1604;&#1576;&#1575;&#1581;&#1579;&#1608;&#1606; &#1571;&#1590;&#1583;&#1575;&#1583;&#1614; &#1575;&#1604;&#1587;&#1607;&#1605;&#1610;&#1575;&#1578; &#1575;&#1604;&#1603;&#1604;&#1576;&#1610;&#1577; &#1604;&#1583;&#1609; 29 &#1591;&#1601;&#1600;&#1604;&#1575;&#1611; (5.3%)&#1548; &#1601;&#1610; &#1581;&#1610;&#1606; &#1603;&#1575;&#1606;&#1578; &#1604;&#1583;&#1609; 19 &#1591;&#1601;&#1600;&#1604;&#1575;&#1611; (3.5%) &#1573;&#1610;&#1580;&#1575;&#1576;&#1610;&#1577; &#1581;&#1583;&#1610;&#1577;&#1548; &#1605;&#1605;&#1575; &#1610;&#1580;&#1593;&#1604; &#1605;&#1593;&#1583;&#1604; &#1575;&#1606;&#1578;&#1588;&#1575;&#1585; &#1583;&#1575;&#1569; &#1575;&#1604;&#1587;&#1607;&#1605;&#1610;&#1575;&#1578; &#1610;&#1589;&#1604; &#1573;&#1604;&#1609; 8.8%&#1548; &#1608;&#1604;&#1605; &#1610;&#1580;&#1583; &#1575;&#1604;&#1576;&#1575;&#1581;&#1579;&#1608;&#1606; &#1601;&#1585;&#1608;&#1602;&#1575;&#1611; &#1610;&#1615;&#1593;&#1618;&#1578;&#1614;&#1583;&#1617;&#1615; &#1576;&#1607;&#1575; &#1573;&#1581;&#1589;&#1575;&#1574;&#1610;&#1575;&#1611; &#1605;&#1606; &#1581;&#1610;&#1579; &#1578;&#1608;&#1586;&#1593; &#1575;&#1604;&#1580;&#1606;&#1587; &#1608;&#1575;&#1604;&#1593;&#1605;&#1585; &#1608;&#1605;&#1581;&#1604; &#1575;&#1604;&#1573;&#1602;&#1575;&#1605;&#1577;.]]></p></abstract>
</article-meta>
</front><body><![CDATA[ <p align="right"><font face="verdana" size="2"><b>RESEARCH ARTICLES</b></font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b>Seroprevalence    of toxocariasis in children aged 1-9 years in western Islamic Republic of Iran,    2003 </b></font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Séroprévalence    de la toxocariose chez l'enfant de 1 à 9 ans dans la région occidentale de la    République islamique d'Iran en 2003</b></font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>&#1605;&#1593;&#1583;&#1604;    &#1575;&#1604;&#1575;&#1606;&#1578;&#1588;&#1575;&#1585; &#1575;&#1604;&#1605;&#1589;&#1604;&#1610;    &#1604;&#1583;&#1575;&#1569; &#1575;&#1604;&#1587;&#1607;&#1605;&#1610;&#1575;&#1578;    &#1576;&#1610;&#1606; &#1575;&#1604;&#1571;&#1591;&#1601;&#1575;&#1604; &#1605;&#1606;    &#1593;&#1605;&#1585; 1 &#1573;&#1604;&#1609; 9 &#1587;&#1606;&#1608;&#1575;&#1578;    &#1601;&#1610; &#1594;&#1585;&#1576; &#1580;&#1605;&#1607;&#1608;&#1585;&#1610;&#1577;    &#1573;&#1610;&#1585;&#1575;&#1606; &#1575;&#1604;&#1573;&#1587;&#1604;&#1575;&#1605;&#1610;&#1577;    &#1587;&#1606;&#1577; 2003</b></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>M. Fallah<sup>I;</sup>    A. Azimi<sup>II</sup>; H. Taherkhani<sup>III</sup> </b></font></p>     ]]></body>
<body><![CDATA[<p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&#1605;&#1581;&#1605;&#1583;    &#1601;&#1604;&#1575;&#1581;&#1548; &#1571;&#1601;&#1588;&#1610;&#1606; &#1593;&#1592;&#1610;&#1605;&#1610;&#1548;    &#1581;&#1588;&#1605;&#1578; &#1575;&#1604;&#1604;&#1607; &#1591;&#1575;&#1607;&#1585;&#1582;&#1575;&#1606;&#1610;</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>I</sup>Department    of Parasitology and Mycology, School of Medicine, Hamadan University of Medical    Sciences, Hamadan, Islamic Republic of Iran (Correspondence to M. Fallah: <a href="mailtodpvrfd">mohfall@yahoo.com</a>)    <br>   <sup>II</sup>Atieh Hospital, Hamadan, Islamic Republic of Iran    <br>   <sup>III</sup>Gorgan University of Medical Sciences, Gorgan, Islamic Republic    of Iran</font></p>     <p align="right">&nbsp;</p>     <p>&nbsp;</p> <HR size="1" noshade>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ABSTRACT</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> We determined    the seroprevalence of Toxocara canis infection in 544 children under 10 years    randomly selected from urban and rural areas of Hamadan. An enzyme-linked immunosorbent    assay was used for detection of antibodies to T. canis excretion-secretion antigens.    Using a questionnaire, epidemiological factors associated with infection were    examined, including age, sex, residence. Antibodies to T. canis were detected    in 29 children (5.3%) and 19 children (3.5%) were categorized as borderline    positive; thus together this gave a prevalence of toxocariasis of 8.8%. No significant    differences were found in terms of sex, age and residence. </font></p> <hr size="1" noshade>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>R&Eacute;SUM&Eacute;</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> Nous avons déterminé    la séroprévalence de l’infection à Toxocara canis chez 544 enfants de moins    de 10 ans résidant dans les zones rurales et urbaines d’Hamadan et sélectionnés    au hasard. La détection des anticorps contre les antigènes excrétoires-sécrétoires    de T. canis a été effectuée à l’aide d’un test immunoenzymatique (ELISA, pour    enzyme-linked immunosorbent assay). Un questionnaire a permis l’évaluation des    facteurs épidémiologiques associés à l’infection, notamment l’âge, le sexe et    le lieu de résidence. Des anticorps anti-T. canis ont été détectés chez 29 enfants    (5,3 %), tandis qu’une positivité limite a été enregistrée chez 19 autres (3,5    %), établissant ainsi une prévalence de la toxocariose à 8,8 %. Aucune différence    significative n’est apparue liée à l’âge, au sexe ou au lieu de résidence.</font></p> <hr size="1" noshade>     ]]></body>
<body><![CDATA[<p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&#1575;&#1604;&#1582;&#1604;&#1575;&#1589;&#1600;&#1577;</b></font></p>     <p align="right"> <font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#1583;&#1585;&#1587;    &#1575;&#1604;&#1576;&#1575;&#1581;&#1579;&#1608;&#1606; &#1605;&#1593;&#1583;&#1604;    &#1575;&#1604;&#1575;&#1606;&#1578;&#1588;&#1575;&#1585; &#1575;&#1604;&#1605;&#1589;&#1604;&#1610;    &#1604;&#1604;&#1593;&#1583;&#1608;&#1609; &#1576;&#1575;&#1604;&#1587;&#1607;&#1605;&#1610;&#1575;&#1578;    &#1575;&#1604;&#1603;&#1604;&#1576;&#1610;&#1577; &#1604;&#1583;&#1609; 544    &#1591;&#1601;&#1604;&#1575;&#1611; &#1583;&#1608;&#1606; &#1587;&#1606; &#1575;&#1604;&#1593;&#1575;&#1588;&#1585;&#1577;&#1548;    &#1575;&#1582;&#1578;&#1610;&#1585;&#1608;&#1575; &#1593;&#1588;&#1608;&#1575;&#1574;&#1610;&#1575;&#1611;    &#1605;&#1606; &#1575;&#1604;&#1605;&#1606;&#1575;&#1591;&#1602; &#1575;&#1604;&#1585;&#1610;&#1601;&#1610;&#1577;    &#1608;&#1575;&#1604;&#1581;&#1590;&#1585;&#1610;&#1577; &#1601;&#1610; &#1607;&#1605;&#1583;&#1575;&#1606;.    &#1608;&#1575;&#1587;&#1578;&#1582;&#1583;&#1605;&#1608;&#1575; &#1605;&#1602;&#1575;&#1610;&#1587;&#1577;    &#1575;&#1604;&#1605;&#1605;&#1578;&#1586; &#1575;&#1604;&#1605;&#1606;&#1575;&#1593;&#1610;    &#1575;&#1604;&#1605;&#1585;&#1578;&#1576;&#1591; &#1576;&#1575;&#1604;&#1573;&#1606;&#1586;&#1610;&#1605;    &#1604;&#1603;&#1588;&#1601; &#1571;&#1590;&#1583;&#1575;&#1583; &#1575;&#1604;&#1587;&#1607;&#1605;&#1610;&#1575;&#1578;    &#1575;&#1604;&#1603;&#1604;&#1576;&#1610;&#1577; &#1608;&#1605;&#1587;&#1578;&#1590;&#1583;&#1575;&#1578;    &#1605;&#1601;&#1585;&#1594;&#1575;&#1578;&#1607;&#1575; &#1608;&#1605;&#1601;&#1585;&#1586;&#1575;&#1578;&#1607;&#1575;&#1563;    &#1608;&#1583;&#1585;&#1587;&#1608;&#1575;&#1548; &#1576;&#1575;&#1587;&#1578;&#1582;&#1583;&#1575;&#1605;    &#1575;&#1587;&#1578;&#1576;&#1610;&#1575;&#1606; &#1582;&#1575;&#1589;&#1548;    &#1575;&#1604;&#1593;&#1608;&#1575;&#1605;&#1604;&#1614; &#1575;&#1604;&#1573;&#1576;&#1610;&#1583;&#1610;&#1605;&#1610;&#1608;&#1604;&#1608;&#1580;&#1610;&#1577;    &#1575;&#1604;&#1605;&#1585;&#1575;&#1601;&#1602;&#1577; &#1604;&#1604;&#1593;&#1583;&#1608;&#1609;&#1548;    &#1608;&#1578;&#1588;&#1605;&#1604; &#1575;&#1604;&#1593;&#1605;&#1585;&#1548;    &#1608;&#1575;&#1604;&#1580;&#1606;&#1587;&#1548; &#1608;&#1605;&#1581;&#1604;    &#1575;&#1604;&#1573;&#1602;&#1575;&#1605;&#1577;. &#1608;&#1575;&#1603;&#1578;&#1588;&#1601;    &#1575;&#1604;&#1576;&#1575;&#1581;&#1579;&#1608;&#1606; &#1571;&#1590;&#1583;&#1575;&#1583;&#1614;    &#1575;&#1604;&#1587;&#1607;&#1605;&#1610;&#1575;&#1578; &#1575;&#1604;&#1603;&#1604;&#1576;&#1610;&#1577;    &#1604;&#1583;&#1609; 29 &#1591;&#1601;&#1600;&#1604;&#1575;&#1611; (5.3%)&#1548;    &#1601;&#1610; &#1581;&#1610;&#1606; &#1603;&#1575;&#1606;&#1578; &#1604;&#1583;&#1609;    19 &#1591;&#1601;&#1600;&#1604;&#1575;&#1611; (3.5%) &#1573;&#1610;&#1580;&#1575;&#1576;&#1610;&#1577;    &#1581;&#1583;&#1610;&#1577;&#1548; &#1605;&#1605;&#1575; &#1610;&#1580;&#1593;&#1604;    &#1605;&#1593;&#1583;&#1604; &#1575;&#1606;&#1578;&#1588;&#1575;&#1585; &#1583;&#1575;&#1569;    &#1575;&#1604;&#1587;&#1607;&#1605;&#1610;&#1575;&#1578; &#1610;&#1589;&#1604;    &#1573;&#1604;&#1609; 8.8%&#1548; &#1608;&#1604;&#1605; &#1610;&#1580;&#1583;    &#1575;&#1604;&#1576;&#1575;&#1581;&#1579;&#1608;&#1606; &#1601;&#1585;&#1608;&#1602;&#1575;&#1611;    &#1610;&#1615;&#1593;&#1618;&#1578;&#1614;&#1583;&#1617;&#1615; &#1576;&#1607;&#1575;    &#1573;&#1581;&#1589;&#1575;&#1574;&#1610;&#1575;&#1611; &#1605;&#1606; &#1581;&#1610;&#1579;    &#1578;&#1608;&#1586;&#1593; &#1575;&#1604;&#1580;&#1606;&#1587; &#1608;&#1575;&#1604;&#1593;&#1605;&#1585;    &#1608;&#1605;&#1581;&#1604; &#1575;&#1604;&#1573;&#1602;&#1575;&#1605;&#1577;.</font></p> <hr size="1" noshade>     <p align="right">&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Introduction</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><i>Toxocara</i>    <i>canis</i> is one of the commonest nematodes of the dog and most often this    nematode is the cause of toxocariasis (visceral larva migrans) &#91;<i>1</i>&#93;. People    become infected by ingestion of eggs from soil, dirty hands (thumb-sucking)    and raw vegetables. Pica has an important role in the acquisition of this infection.    Once embryonated eggs are ingested, the larvae hatch and migrate through the    somatic organs &#91;<i>2</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In humans, migration    of <i>T.</i> <i>canis</i> larvae to viscera and other organs produces visceral    larva migrans syndrome, and sometimes ocular larva migrans and neurotoxocariasis    &#91;<i>3</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Toxocariasis is    considered to be a disease mainly of children, although adults can also be affected.    Children are more at risk of acquiring this infection because of their attraction    to pets (dogs and cats) and their play habits, which may expose them to accidental    ingestion of <i>Toxocara</i> eggs from the animal hosts.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Direct confirmation    of larva in internal organs is extremely difficult. Emphasis is placed on diagnosing    visceral larva migrans and ocular larva migrans by indirect serological methods    &#91;<i>4</i>&#93;. Diagnosis of human toxocariasis through most immunological tests    is done using <i>T. canis</i> excretion-secretion antigens, most often by enzyme-linked    immunosorbent assay (ELISA) &#91;<i>5,6</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">There have been    few epidemiological studies on the prevalence of toxocariasis in the Islamic    Republic of Iran, especially in western parts such as Hamadan, except some sporadic    reports of disease in children &#91;<i>7</i>&#93;. In this province human ascariasis    is endemic and canine ascarids are common as well &#91;<i>8</i>&#93;. In central Hamadan,    <i>Ascaris lumbricoides</i> prevalence is reported to be 20%, and the prevalence    of canine ascarids is reported to be about 51% in stray dogs &#91;<i>9</i>&#93; and    there are thousands of stray dogs in and around the city without any control    measures. Soil-contamination by <i>Toxocara</i> eggs in public parks has been    reported previously &#91;<i>10,11</i>&#93; and clinical evidence suggests the presence    of human toxocariasis in this region. Environmental and sociocultural conditions    facilitate infection with <i>Toxocara</i> eggs in humans, especially children.    As there is a lack of documented reports on the seroepidemiology of toxocariasis    in our area, we aimed to assess the prevalence of the infection in children    under 10 years of age and its association with certain factors.</font></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Methods</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The study was carried    out from July to September 2003 in Hamadan. The total population of Hamadan    is about 600 000, and the target population (under 10 years old) was about 101    000 &#91;<i>12</i>&#93;. A total of 544 children aged 1-9 years (278 girls and 276 boys)    were randomly selected from urban (408, 75%) and rural (136, 25%) areas of Hamadan.    The children were selected from areas covered by 10 health centres in the city    and 9 health centres in the rural areas. All members of households in the catchment    areas of the health centres have a health file and code and this was the sampling    frame from which the children were selected. Sample size was calculated proportionally    according to residence with a probable prevalence of 15% in urban areas and    3% in rural areas with 95% confidence interval.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Data were collected    using a questionnaire which included epidemiological factors such as age, sex,    residence, parents’ educational status, a history of close contact with dogs    and/or cats, keeping pets in the home, exposure to soil, pica, eating raw vegetables,    mode of vegetable washing, thumb-sucking and frequency of visits to outdoor    parks. The questionnaires were completed by the parents and health staff.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Venous blood samples    (3 mL) were collected from each child for detection and titration of antibodies    to <i>T. canis</i>. Serum was separated on the same day as collection at the    centre and then frozen at -20 °C until analysis. Informed consent was obtained    from the parents for their child to participate.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The ELISA/IgG diagnostic    kit was supplied by Test-Line Ltd Clinical Diagnostics, Czech Republic. The    manufacturer claims a high specificity of 99.2% and sensitivity of 100%. The    ELISA procedure was carried out according to the manufacturer’s instructions.    An automated washer (Asys Sera Washer, Austria) and automated reader (Rosys    Authos, Spain) were also used. The base serum dilution in this method was 1/200.    The intensity of colour of each well was read at 450 nm against the blank. Results    were considered valid if the absorbance of the blank was less than 0.150, of    the positive control was <u>&gt;</u> 0.900 and of the negative control was <u>&lt;</u>    0.200, and the mean absorbance of cut-off was between 0.250 and 0.600. For evaluation    of the results, index positivity was used (absorbance of each tested sample    divided by the mean absorbance of the cut-off that was obtained in the same    test); the cut-off was calculated and appointed to 0.3. According to the manufacturer    recommendations, an index positivity &gt; 1.1 was considered positive, 0.9 to    1.1 as borderline and &lt; 0.8 as negative for <i>T. canis</i> infection.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Statistical    analysis</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Data were analysed    by <i>SPSS</i>, version 10 and the chi-squared test was used to assess statistical    differences. <i>P</i> &lt; 0.05 was considered significant.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Results</b></font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Of the 544 samples    analysed, 29 were positive for <i>Toxocara</i> antibodies giving an overall    prevalence of 5.3%, obtained at a cut-off titre of 1/200. In addition, 19 (3.5%)    of the samples had a borderline titre. Thus including the borderline cases as    positive, we have a prevalence of toxocariasis of 8.8%. Of the 29 children positive    for toxocariasis, 24 had a low titre, 4 a medium titre and only 1 had a high    titre (<a href="#tab1">Table 1</a>). <a href="#tab1">Table 1</a> also shows    the prevalence of antibodies to <i>Toxocara</i> according to age, sex and residence;    other variables examined were either not significant or incomplete and were    excluded and are not shown. There was no significant difference in the seropositivity    according to sex (5.3% males, 5.63% females, <i>P</i> = 0.54) or age group (1-3    years 5.66%, 4-6 years 5.3% and 7-9 years 5.28%, <i>P</i> = 0.97). Although    a lower prevalence was found in the urban areas (5.63%) compared with the rural    areas (4.41%), this was not statistically significant (<i>P</i> = 0.69).</font></p>     <p><a name="tab1"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/emhj/v13n5/a10tab01.gif"></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Discussion</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">We found the prevalence    of confirmed toxocariasis to be 5.3%; with the borderline cases included, this    rose to 8.8%. We expected a higher prevalence rate in this region because of    the environmental and cultural conditions. Because the prevalence of infection    varies in difference geographical regions, it may be that the positivity index    recommended by the manufacturers is not appropriate for developing countries    such as ours and the assessment of antibodies should, as much as is practical,    take account of special regional conditions.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Seropositive rates    for <i>T. canis</i> have been reported to be 2.8% in the general population    and 4.6%-7.3% in children 1-11 years old in the United States &#91;<i>11</i>&#93;, 10.9%    in Jordan &#91;<i>13</i>&#93;, 25.6% (132/519) in Shiraz, eastern Islamic Republic of    Iran &#91;<i>8</i>&#93; and 3.1% (70/2129) in Ireland &#91;<i>14</i>&#93;. Other studies report    seropositivity rates of 3.1% (16/314) in Korea &#91;<i>15</i>&#93;, 17.7% and 2.1% in    rural and urban children respectively in China &#91;<i>16</i>&#93;, 62.3% in schoolchildren    in Trinidad &#91;<i>17</i>&#93;, and 3.6% and 17.2% in 2 different areas of Spain (Madrid    and Tenerife) &#91;<i>18</i>&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">While we expected    a higher seropositivity rate among this group of children, nonetheless the rate    of 8.8% was considerably higher than that expected for the general population    (2.0% to 2.5%). The absence of a significant difference in the rate of positivity    between families who owned a dog and those that did not suggests that infection    was being acquired from communal sources such as parks and playgrounds. Soil    contamination of public parks and playgrounds in Hamadan has been reported previously    &#91;<i>10</i>&#93;. Furthermore, keeping dogs is not popular in either urban or rural    areas because of Islamic beliefs about dogs. Therefore, the contamination of    the environment with <i>T. canis</i> eggs from stray dogs is probably the common    source of infestation of children. The potential transmission of infection in    children is undoubtedly greater than adults because children often play in the    contaminated environments. The considerable proportion of children who had been    infected indicates the need for control of the canine pollution in the area.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In conclusion,    the prevalence of toxocariasis among children in western parts of the Islamic    Republic of Iran is the same as some other developing countries but lower than    southern parts of the country. Nevertheless, it is relatively high, as is the    prevalence of canine ascarids in this area and soil contamination of public    parks with eggs. Therefore, toxocariasis does constitute a health problem in    this area that needs to be addressed.</font></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Acknowledgements</b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">We thank the Deputy    of Education, Hamadan University of Medical Sciences, who funded the study.    We also thank the personnel of all the urban and rural health centres of Hamadan    for their help in the collection of samples.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>References</b></font></p>     <!-- ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1.   Liu XL. Toxocariasis    and larva migrans syndromes. In: Guerrant RL, Walker DH, Weller PF, eds. <i>Tropical    infectious diseases</i>, vol. 2. Philadelphia, Churchill Livingstone, 1999:907-15</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=004165&pid=S1020-3397200700050001100001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2.   Schantz PM.    <i>Toxocara</i> larva migrans now. <i>American journal of tropical medicine    and hygiene</i>, 1989, 41(3 suppl.):21-34.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3.   Gillespie    SH et al. The spectrum of ocular toxocariasis. <i>Eye</i>, 1993, 7:415-8.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4.   Sommer C et    al. Adult <i>Toxocara canis</i> encephalitis. <i>Journal of neurology, neurosurgery,    and psychiatry</i>, 1994, 57:229-31.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5.   Jaquier P    et al. Immunodiagnosis of toxocariasis in human: evaluation of a new enzyme-linked    immunosorbent assay kit. <i>Journal of clinical microbiology</i>, 1991, 29(9):1831-5.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6.   Yamasaki H    et al. Development of a highly specific recombinant <i>Toxocara canis</i> second-stage    larva excretory-secretory antigen for immunodiagnosis of human toxocariasis.    <i>Journal of clinical microbiology</i>, 2000, 38(4):1409-13.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7.   Sadjjadi SM    et al. Seroprevalence of <i>Toxocara </i>infection in school children in Shiraz,    southern Iran. <i>Journal of tropical pediatrics</i>, 2000, 46:327-30.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8.   Fallah M.    &#91;<i>Toxocara canis</i>: infection of stray dogs and visceral larva migrans risk    in Hamadan&#93;. <i>Scientific journal of Hamadan University of Medical Sciences</i>,    1995, 2(2):18-22 &#91;in Farsi&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9.   Fallah M et    al. Evaluation of two years mass chemotherapy against ascariasis in Hamadan,    Islamic Republic of Iran. <i>Bulletin of the World Health Organization</i>,    2002, 80(5):399-402.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10.  Fallah M,    Majzoubi MM. <i>Soil contamination of Hamadan public parks with ova of parasites    and cyst and oocysts of protozoa</i>. Paper presented at the 3rd Iranian Congress    for Environmental Health, Kerman, Islamic Republic of Iran, 2000.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11.  Herrmann N    et al. Seroprevalence of zoonotic toxocariasis in the United States: 1971-1973.    American <i>journal of epidemiology</i>, 1985, 122:890-6.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12.  Statistics    Center of the Islamic Republic of Iran. &#91;<i>A monograph of Iranian National    Census in 1996</i>&#93;. The Hamadan, Management and Planning Organization, 1997    &#91;in Farsi&#93;.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">13.  Abo-Shehada    MN et al. Seroprevalence of <i>Toxocara canis </i>antibodies in humans in northern    Jordan. <i>Journal of helminthology</i>, 1992, 66:75-8.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">14.  Holland CV    et al. Seroepidemiology of toxocariasis in school children. <i>Parasitology</i>,    1995, 110:535-45.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">15.  Park HY et    al. A seroepidemiological survey for toxocariasis in apparently healthy residents    in Gangwon-do, Korea. <i>Korean journal of parasitology</i>, 2002, 40(3):113-7.</font></p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">16.  Zhong-jin    Luo et al. Detection of circulating antigens and antibodies in <i>Toxocara canis</i>    infection among children in Chengdu, China. <i>Journal of parasitology</i>,    85(2), 1999:252-6.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">17.  Baboolal S,    Rawlins SC. Seroprevalence of toxocariasis in children in Trinidad. <i>Transactions    of the Royal Society of Tropical Medicine and Hygiene</i>, 2002, 96:139-43.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">18.  Fenoy S, Cuellar    C, Guillen JL. Seroprevalence of toxocariasis in children and adults in Madrid    and Tenerife, Spain. <i>Journal of helminthology</i>, 1996, 70:109-13.</font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Received: 18/05/05;    accepted: 07/07/05 </font></p>      ]]></body>
<REFERENCES></REFERENCES<back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[XL.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Toxocariasis and larva migrans syndromes]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Guerrant]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
<name>
<surname><![CDATA[Weller]]></surname>
<given-names><![CDATA[PF]]></given-names>
</name>
</person-group>
<source><![CDATA[Tropical infectious diseases]]></source>
<year>1999</year>
<volume>2</volume>
<page-range>907-15</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Churchill Livingstone]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
